Article Versions Notes

Zhou AW, Teagle GM, Baumann LM, Cao JA, Emanuelli A, Hu AY, Berger AS, Major JC Jr., Lee SY, Huddleston SM, et al. Intravitreal Aflibercept for the Treatment of Diabetic Retinopathy Among Patients Who Completed PANORAMA: 1-Year Outcomes from the VOYAGE Extension Study. Journal of Personalized Medicine. 2025; 15(11):555. https://doi.org/10.3390/jpm15110555

Zhou, Avery W., Gail M. Teagle, Liisa M. Baumann, Jessica A. Cao, Andres Emanuelli, Allen Y. Hu, Adam S. Berger, James C. Major, Jr., Seong Y. Lee, Stephen M. Huddleston, and et al. 2025. "Intravitreal Aflibercept for the Treatment of Diabetic Retinopathy Among Patients Who Completed PANORAMA: 1-Year Outcomes from the VOYAGE Extension Study" Journal of Personalized Medicine 15, no. 11: 555. https://doi.org/10.3390/jpm15110555

Zhou, A. W., Teagle, G. M., Baumann, L. M., Cao, J. A., Emanuelli, A., Hu, A. Y., Berger, A. S., Major, J. C., Jr., Lee, S. Y., Huddleston, S. M., Gonzalez, V. H., Clark, W. L., Liao, D. S., Kingsley, R. M., Lazarus, H. S., Payne, J. F., Feinstein, E. G., Meleth, A. D., Patel, S. B., ... Wykoff, C. C. (2025). Intravitreal Aflibercept for the Treatment of Diabetic Retinopathy Among Patients Who Completed PANORAMA: 1-Year Outcomes from the VOYAGE Extension Study. Journal of Personalized Medicine, 15(11), 555. https://doi.org/10.3390/jpm15110555